The EU Drugs Strategy proposed by the Commission today takes “a multi-dimensional and whole-of-society approach”, focused on 5 key areas. First, enhancing preparedness and response to drug-related threats, with improved data collection, monitoring, early warning, and rapid response measures at EU and national level. The EU Drugs Agency (EUDA), “with its new, stronger mandate, will play a key role in supporting Member States by identifying new psychoactive substances, issuing rapid alerts, and assessing the risks posed by highly potent synthetic opioids”. Second, protecting public health, by strengthening prevention, treatment and reintegration measures. Third, strengthening security, with stricter rules against organised crime and an evaluation of the existing Framework Decision on drug trafficking by 2026. Fourth area: measures to prevent drug-related harm “focused on protecting young people from recruitment into organised crime”. And finally, stronger partnerships with third countries, to reinforce and expand international alliances, and increase operational cooperation, technical assistance and capacity building.